SutroVax procures $110m Series D

Foster City, California-based SutroVax, a biopharmaceutical company, has secured $110 million in Series D funding.

Foster City, California-based SutroVax, a biopharmaceutical company, has secured $110 million in Series D funding. RA Capital Management and Janus Henderson Investors led the round.

Source: Press Release